One of the largest pharmaceutical companies in North Carolina is discontinuing a treatment produced in the state.

Pfizer will end the global commercialisation of its haemophilia gene therapy Beqvez (fidanacogene elaparvovec) amid low ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

After years of medical issues, columnist G Shellye Horowitz has acquired numerous assistive devices, which come in handy ...

Approved in 2022 by the FDA, Hemgenix is the first gene therapy for the treatment of adults with hemophilia B who currently use factor IX prophylaxis therapy, have current or historical life ...

And now as he's having his worst season as a pro, he's become a member of the Bucks. The Bucks acquired Porter in a trade with the Los Angeles Clippers, a team he joined this season, on Thursday ...

Irish-founded strategic communications and public affairs agency Red Flag Global has been acquired by Ankura Consulting Group. The terms of the deal have not been disclosed but it is understood to ...

U.K.-based sales company Impronta Films has taken global rights to “Canone Effimero,” the latest work by Italy’s twin directorial duo Gianluca and Massimiliano De Serio, ahead of the ...

Doctors at the hospital revealed that initial tests and symptoms pointed to acquired haemophilia – a rare and life-threatening disorder where the body suddenly loses its ability to clot blood properly ...

This course is aimed at SpRs preparing for the part 2 FRCPath examination but is also suitable for clinicians, scientists and biomedical scientists in academia, the NHS, pharmaceutical and diagnostic ...